Shanghai Unicar-therapy Bio-medicine Technology Co.,ltd

This early-stage study is testing a new type of personalized cell therapy called CD30-targeted CAR-T for adults with lymphoma that has come back or not responded to standard treatments. The main goals are to see if the treatment is safe and if it can shrink tumors. Researchers wi…

This early-phase study is testing a new version of CAR-T cell therapy called U01 (ssCART-19) in adults and children (ages 2-75) with B-cell lymphoma that has returned or not responded to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab …